SCHEMBL18697407

SCHEMBL18697407

CC(CC1CCN(C(C)CC2CCN2C(C)C)C1)N1CCCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19730586 0.86
SCHEMBL25823853 0.86 MEN1 (0.32)
SCHEMBL23513066 0.85
SCHEMBL21993492 0.85
SCHEMBL19380559 0.83 HRH3 (0.31)
SCHEMBL18633843 0.83 HRH3 (0.33)
SCHEMBL24250666 0.80
SCHEMBL19960851 0.78 HRH3 (0.33)
SCHEMBL25147448 0.78
SCHEMBL22011389 0.77 CCR2 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230357240-A1 NOVEL N-HETEROCYCLIC BET BROMODOMAIN INHIBITOR, AND PREPARATION METHOD THEREOF AND MEDICAL USE THEREOF CHENGDU EASTON BIOPHARMACEUTICALS CO LTD (CN) 2023-11-09 US disclosed
US-20230112485-A1 THERAPEUTIC COMPOUNDS GENENTECH, INC. (US) 2023-04-13 US disclosed
US-9611268-B2 Modulators of toll-like receptor 7 GILEAD SCIENCES, INC. (US) 2017-04-04 US disclosed